INVENTIVA (EPA:IVA) | WebDisclosure

BRIEF

published on 05/27/2025 at 22:05, 5 days 8 hours ago

Inventiva at the Jefferies and UBS Healthcare Conferences

Biopharmaceuticals Inventiva MASH UBS Conference Jefferies Conference
BRIEF

published on 05/27/2025 at 22:05, 5 days 8 hours ago

Inventiva aux Conférences Jefferies et UBS sur la Santé

Biopharmaceutique Inventiva Conférence Jefferies MASH Conférence UBS
PRESS RELEASE

published on 05/27/2025 at 22:00, 5 days 9 hours ago

Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
Inventiva to participate in Jefferies Global Healthcare Conference & UBS Spring Biotech Conference. CEO to present at fireside chat in New York City

Clinical-stage Biopharmaceutical Company Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
PRESS RELEASE

published on 05/27/2025 at 22:00, 5 days 9 hours ago

Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference »
Inventiva participera à deux conférences investisseurs en juin 2025 : Jefferies Global Healthcare Conference et UBS Spring Biotech Conference. Présentation stratégique de la société et du médicament Lanifibranor

Conférences Investisseurs Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
BRIEF

published on 05/23/2025 at 08:35, 9 days 22 hours ago

Inventiva Reports First Quarter 2025 Financials: Cash Position Declines

Financial Results Cash Position Clinical Trial Inventiva Lanifibranor
BRIEF

published on 05/23/2025 at 08:35, 9 days 22 hours ago

Inventiva publie ses résultats financiers du premier trimestre 2025 : la trésorerie diminue

Résultats Financiers Essai Clinique Situation De Trésorerie Inventiva Lanifibranor
PRESS RELEASE

published on 05/23/2025 at 08:30, 9 days 22 hours ago

Inventiva reports 2025 First Quarter Financial Information¹
Inventiva reports €67.9 million in cash and cash equivalents for Q1 2025. Forecasted funds to support operations until Q3 2026. Key milestones include Phase 3 trial results expected in late 2026

Financial Information Inventiva Q1 2025 Cash Equivalents NATiV3 Trial
PRESS RELEASE

published on 05/23/2025 at 08:30, 9 days 22 hours ago

Inventiva publie ses informations financières¹ du 1er trimestre 2025
Inventiva publie ses informations financières du 1er trimestre 2025, avec une trésorerie de 67,9 millions d'euros. Progrès notables en R&D et publications scientifiques récentes dévoilées

R&D Trésorerie Publications Scientifiques Inventiva Trimestre 2025
BRIEF

published on 05/22/2025 at 14:05, 10 days 16 hours ago

Inventiva dévoile les détails de son programme de rachat d'actions

Rachat D'actions Réduction De Capital Stabilité Du Marché Accord De Liquidité Options D'achat D'actions Des Employés
BRIEF

published on 05/22/2025 at 14:05, 10 days 16 hours ago

Inventiva Unveils Details of Share Repurchase Program

Share Repurchase Liquidity Agreement Capital Reduction Market Stability Employee Stock Options

Published on 06/02/2025 at 01:00, 6 hours 4 minutes ago

Sparta Capital Announces Filing of Interim Financial Statements
Published on 05/31/2025 at 06:16, 2 days ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 2 days 3 hours ago

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 2 days 5 hours ago

GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 2 days 7 hours ago

CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment

View all ACCESSWIRE

Published on 06/02/2025 at 06:55, 9 minutes ago

Leclanché présentera le Navius MRS-3 au salon Nor-Shipping 2025
Published on 06/02/2025 at 06:55, 9 minutes ago

Leclanché to Showcase its Navius MRS-3 at Nor-Shipping 2025
Published on 06/02/2025 at 06:50, 14 minutes ago

Daldrup & Söhne AG achieves EBIT margin of 12.7% in 2024
Published on 06/02/2025 at 06:30, 34 minutes ago

Holcim plans Amrize spin-off for June 23
Published on 06/02/2025 at 06:30, 34 minutes ago

Javier Perez-Freije named new CFO at Bystronic

View all EQS

Published on 05/30/2025 at 22:00, 2 days 9 hours ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 2 days 9 hours ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 2 days 12 hours ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 4 days 8 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 4 days 8 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News